Search results
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And...
Benzinga via AOL· 3 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 9 hours agovaccine and Covid/Influenza combination vaccine candidate, representing a potential multi-billion-dollar revenue opportunity for < ...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 hours agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WKRN Nashville· 4 days ago...worldwide (except in countries with existing Advance Purchase Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 4 Kansas City· 4 days ago...combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 3 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 3 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 13 hours agoA: John Trizzino, Novavax, Inc. - President & Chief Operating...market share and vaccination rates through the combination of COVID and flu vaccines ...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 5 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 2 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British ...